Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ned Tijdschr Geneeskd ; 156(21): A4668, 2012.
Artigo em Holandês | MEDLINE | ID: mdl-22617072

RESUMO

BACKGROUND: Insufficient weight loss after gastric band placement is generally linked to band-related complications or a persistently unhealthy diet. CASE DESCRIPTION: A 47-year-old woman with a history of gastric band placement presented with complaints of decreased mobility, dyspnoea, gastro-oesophageal reflux and a progressive increase in abdominal girth. Initially, these symptoms were attributed to an unhealthy diet. However, additional testing showed a large intra-abdominal multicystic lesion originating from the ovaries. The patient was operated and two large serous cystadenomas were removed, after which the symptoms disappeared almost immediately. CONCLUSION: Abdominal complaints after bariatric surgery can often be explained by surgical complications or unhealthy eating habits. Although the cause of certain complaints is sometimes obvious, alternative diagnoses need to be considered. If the abdominal girth in middle-aged women increases, ovarian disorders must always be considered in the differential diagnosis and appropriate additional diagnostic testing need to be carried out.


Assuntos
Cistadenoma/diagnóstico , Neoplasias Ovarianas/diagnóstico , Dor Abdominal/diagnóstico , Dor Abdominal/etiologia , Cistadenoma/cirurgia , Diagnóstico Diferencial , Feminino , Gastroplastia/efeitos adversos , Humanos , Pessoa de Meia-Idade , Obesidade Mórbida/cirurgia , Neoplasias Ovarianas/cirurgia , Complicações Pós-Operatórias/diagnóstico , Aumento de Peso
2.
Scand J Gastroenterol ; 40(11): 1374-7, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16334449

RESUMO

6-Thioguanine is used as an escape thiopurine for treating inflammatory bowel disease patients intolerant or refractory to azathioprine, 6-mercaptopurine or methotrexate. Case reports show conflicting data on the use of 6-thioguanine throughout pregnancy. The administration of the standard thiopurines is believed to be relatively safe. We describe two patients with Crohn's disease treated with low-dose 6-thioguanine during all trimesters of their pregnancies. The pregnancies resulted in two healthy infants: without congenital abnormalities, laboratory signs of myelosuppression or hepatocellular injury. Thiopurine metabolites were measured in mother and infant. Significantly lower levels of 6-thioguaninenucleotides were found in the erythrocytes of the infant compared to the mother (ratio 1:12). Further studies are needed to determine the clinical importance of thiopurine metabolite measurements during pregnancy in mother and child.


Assuntos
Doença de Crohn/diagnóstico , Doença de Crohn/tratamento farmacológico , Troca Materno-Fetal/efeitos dos fármacos , Complicações na Gravidez/tratamento farmacológico , Resultado da Gravidez , Tioguanina/administração & dosagem , Adulto , Relação Dose-Resposta a Droga , Esquema de Medicação , Feminino , Seguimentos , Idade Gestacional , Humanos , Gravidez , Complicações na Gravidez/diagnóstico , Gravidez de Alto Risco , Medição de Risco , Índice de Gravidade de Doença , Tioguanina/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...